ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666295 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666295; 2) Community: the network communities that were significantly associated with the response to NSC 666295; 3) Molecule: the relationships between components within communities and NSC 666295; 4) MDR: the compounds that were significantly associated with the NSC 666295.

NSC Compound Enrichment Correlation
NSC 339137 PHYSALOLACTONE 0.0490935610249067 0.3557893
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0490935610249067 0.48860926
NSC 55236 Null 0.0490935610249067 0.30659524
NSC 604976 Verrucarin A, 7'-deoxo-2'-deoxy-2',3'-epoxy-8',9',10',11'- tetrahydro-4',8-dihydroxy-7'-(1-hydroxyethyl)- 0.0490935610249067 0.25917651
NSC 606499 Camptothecin Derivative 0.0490935610249067 0.2106963
NSC 609259 Null 0.0490935610249067 0.31504884
NSC 617394 Null 0.0490935610249067 0.49840062
NSC 629229 Null 0.0490935610249067 0.12075523
NSC 638409 (E)N-Ethyl-[3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl) prop-2-enoamide 0.0490935610249067 0.37594849
NSC 642324 Null 0.0490935610249067 0.15020622
Total:148  Current:142    [First] [Prev] [Next] [Last]